Article
A Randomized Controlled Trial of Intranasal Oxytocin in Phelan-McDermid Syndrome
2021-03-05
Abstract excerpt
<title>Abstract</title> <p>BackgroundPhelan-McDermid syndrome (PMS) is a rare neurodevelopmental disorder caused by haploinsufficiency of the SHANK3 gene and characterized by global developmental delays, deficits in speech and motor function, and autism spectrum disorder (ASD). Monogenic causes of ASD such as PMS are well suited to investigations with novel therapeutics, as interventions can be targeted based on...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 85aef7d8-9456-532a-a993-0c2db435474d
- DOI
- 10.21203/rs.3.rs-268151/v1
